Introduction
The termination of myxoedema in coma was described in the Report of the Clinical Society of London-(i888) and had been noted even before this (St. Thomas's Hospital Report, I879) . It is an uncommon complication occurring in longstanding untreated cases and hitherto was fatal, with the possible exception of one patient (Malden, 1955) , and here the cerebro-spinal fluid protein was markedly raised and on recovery there was a unilateral hypereflexia suggesting a cerebrovascular accident complicating myxoedema.
This article reports the successful treatment of an undoubted case of myxoedema coma with oral tri-iodo-thyronine. Case Report
Mrs. E. A., aged 69, was admitted to Walton Hospital at 8.30 p.m. on January 22, I957, as a case of ' apoplexy.' The casualty officer noted that she was unconscious.
The relatives said that she had felt the cold excessively for many years and her face had become puffy over the last I2 months. For six months she had restricted her activities and been troubled with deafness. During the previous week she was drowsy, had taken to sleeping during the afternoon, and on the day of admission was found to be unrousable in her chair.
The patient had had three normal deliveries, the last 25 years ago, and had menstruated again after the last pregnancy.
On examination the patient was comatose. She had a typical myxoedematous facies, the skin was cold and dry, the axillae were dry and hairless, the vulval hair was absent and the labial hair sparse. She could not talk, but was capable of making croaking noises on painful stimulation.
The pulse rate was 52 per minute and regular, the blood pressure I8o/ioo, and the heart sounds very distant. There was no evidence of neurological abnormality apart from absent ankle jerks, but the ocular fundi could not be adequately ..
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iodo-thyronine administered in a milk drip commencing at 6 p.m. The next day (January 24) she could just speak a few words and she was slowly returning to a normal conscious level. The pulse rate was 88 per minute and the rectal temperature 990 F. She was put on 40 1lg. of tri-iodo-thyronine daily by mouth.
At II.30 p.m. on January 25 she had become very restless and was singing in the wvard. It was considered that she had become mentally hyperactive following tri-iodo-thyronine therapy and she was sedated with paraldehyde ml. I.M. and the tri-iodo-thyronine suspended until January 27 (when she was started on 20 [tg. daily), by which time although still slightly confused and noisy she was more rational.
Over the next two davs she made a remarkable recovery, becoming quite rational and able to walk about the ward. Now that she was cooperative a B.M.R. was performed (February 2) and gave a result of minus 25 per cent. An E.E.G. (February 6) was reported by Dr. E. A. Nieman as' there is a well-developed regular 8 per second alpha rhythm and some slow activity within the theta range,' a picture found in cases of myxoedema. Chext X-ray showed no pulmonary pathology and the heart size was within normal limits.
On February I3 she complained of vomiting and admitted to having not felt well the previous day, but she denied any chest pain. Examination showed her to be in mild congestive heart failure. She was put to bed, digitalized, given mercurial diuretics, a salt-free diet and the tri-iodo-thyronine was discontinued. By February i6 her vomiting had settled, the heart failure improved and she was given cortisone 25 mg. twice daily (because the possibility of a hypopituitary state was entertained) and the tri-iodo-thyronine in a dose of 20 vg. dailv recommenced.
On February i8 she complained of palpitations and breathlessness, the pulse rose to II0 per minute, the blood pressure fell to i io,16o (the rectal temperature was 97.4 F.), and she wvas fourid to be in severe congestive heart failure. She collapsed shortly afterwards and died.
Post Mortem
There was oedema of the ankles and about 200 ml. of clear fluid was found in both pleural cavities. The lungs, liver and spleen were congested, but otherwise of normal appearance. There was severe atheroma of the coronary arteries and the right coronary artery contained atheromatous debris on which was superimposed a recent (still red) thrombus for a distance of 2 cm. The myocardium of the posterior wall of the left ventricle and of part of the septum showed a diffuse extensive infarction. There was very advanced atheroma of the aorta and the mesenteric arteries. The uterus and ovaries appeared normal for her age.
On histological examination the thyroid was very small and weighed 3.8 g. It consisted practically entirely of fibrous tissue in which only occasional tiny islets of atrophic thyroid tissue were found.
The adrenals were of normal size (S.8 and 6.2 g.).
The cortex contained only a moderate amount of lipoid. The zona reticulata appeared slightly atrophic; there were a number of small hyperplastic nodules in the zona glomerulosa. The adrenal medulla contained numerous large Russel bodies and some of the medullary cells in the vicinity had very large nuclei.
The pituitary weighed i g. The general structure was normal, but many of the basophil cells contained small vacuoles. The proportion of the different types of cells was normal. The pancreas appeared normal and healthy on naked-eye and microscopic examination. Both ovaries showed senile atrophy with no trace of ova. Only one parathyroid was found. This showed normal histological appearances and had the usual islets of eosinophil cells.
Discussion
This was a case of primary myxoedema which (Caughey and Garrod, 1954) . It can also be classified into several relatively well-defined types, namely, hypoglycaemic, hypothermic or electrolyte imbalance/water retaining (Sheehan and Summers, 1952) , and the treatment is to correct the pertinent abnormality.
The almost constant finding of hypothermia in myxoedema coma would suggest the application of heat to the patient. A heat cradle was used in this instance, but it has been shown that thevelevation of body temperature in itself is insufficient to produce recovery, in contradistinction to its successful use in hypothermic hypopituitary coma (Sheehan and Summers, I952) . It is interesting to note that a case of myxoedema coma has been described in which the patient was febrile (Karhausen and Zylberszac, 1955) .
Experience with 3-5-3'-1-tri-iodo-thyronine has demonstrated its potency in myxoedema (Gross, Pitt-Rivers and Trotter, I952; Asper, Selenkow and Plamondon, 1953; Deltour and Bekaert, 1953; Lerman, I954) and shown that whereas its short duration of action precludes routine use in hypothyroid patients (Frawley, McClintock, Beebe and Marthy, 1956) , its rapidity of action makes it the logical therapy in myxoedema coma. i,00o0 ,g. of tri-iodo-thyronine given intravenously to a case of myxoedema (Rawson et al., 1953) was shown to raise the B.M.R. appreciably in seven hours and to exert its maximal effect in 24 hours, whereas 1-thyroxine in a dose of 3 mg. I.V. produced a slight rise in the B.M.R. in 24 hours and a maximal effect in I I days. A comparable rapidity in action has been noted with oral administration (Zondek, Leszynsky and Zondek, 1955) .
Two reports of its use in myxoedema coma have appeared in this country and in both cases, despite some improvement, the patient died before attaining a euthyroid state (Dyson and Clinical trials of prochlorperazine in psychoses have been in progress in mental hospitals in the United Kingdom and abroad for more than two years. Evidence from these widespread studies, some of which are still in progress, has indicated that prochlorperazine is a valuable addition to those drugs already available for the management of psychotic illnesses.
The primary indication of ' Stemetil' is in the management of schizophrenia. In many cases ' Stemetil ' may make withdrawn, autistic, catatonic cases amenable to psychotherapy at a relatively early stage in treatment. It may be employed successfully in the management of excitement whether associated with schizophrenia, the manic-depressive psychosis, or other psychiatric conditions wherein agitation and excitement are notable features. Although the drug has been used on a very large number of patients, no case of jaundice or blood dyscrasia attributable to its use has been reported. 
